IndiaMTF — home
Stock

SHILPAMED

Shilpa Medicare Limited
Health Technology

Daily Margin Trading Facility book for SHILPAMED across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹140 Cr
as of 10 Sep 2026
Rank in book
#276
268 days tracked
Share of book
0.09%
of the whole NSE + BSE book
Peak funded
₹170 Cr
on 01 Sep 2026
Largest single-day addition
+₹22 Cr
on 26 May 2025
Largest single-day unwind
−₹26 Cr
on 11 Nov 2025

NSE & BSE split

How SHILPAMED’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹138 Cr · 97.9%BSE ₹3 Cr · 2.1%

MTF vs Price

Margin-funded outstanding for SHILPAMED in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹961.15
as of 11 Sep 2026
Price, 30 days
+57.2%
adjusted for splits and bonuses
Delivery, 20-day avg
41.5%
of traded volume actually settled
Sessions to unwind
4.5
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹0+0.0%−0.1%
−1,432
−2.2%unwinding as it falls
10 days−₹26−15.5%−14.2%
−3,70,375
+4.2%unwinding into strength
30 days+₹41+41.2%+9.6%
+1,97,272
+55.9%building into strength
90 days+₹39+39.0%−3.8%
−88,557
+71.9%unwinding into strength
180 days+₹126+875.7%+471.4%
+18,50,192
+192.6%building into strength
1 year+₹60+75.0%+104.1%
+11,43,819
+186.0%building into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where SHILPAMED has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

SHILPAMED — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026140+₹00.09%276
09 Sep 2026140+₹40.09%273
08 Sep 2026136−₹30.09%285
07 Sep 2026139−₹200.09%281
04 Sep 2026160−₹20.10%242
03 Sep 2026161−₹50.10%239
02 Sep 2026167−₹40.11%227
01 Sep 2026170+₹110.11%218
31 Aug 2026160−₹20.10%238
28 Aug 2026161−₹50.11%232
27 Aug 2026166+₹190.11%224
26 Aug 2026147+₹00.10%257
25 Aug 2026147+₹20.10%258
24 Aug 2026145+₹110.10%259
21 Aug 2026134−₹10.09%279
20 Aug 2026135+₹80.09%277
19 Aug 2026128−₹20.09%296
18 Aug 2026130−₹10.09%291
17 Aug 2026131+₹00.09%286
14 Aug 2026130+₹50.09%283
13 Aug 2026126+₹20.09%292
12 Aug 2026124−₹10.08%299
11 Aug 2026125+₹10.09%292
10 Aug 2026124+₹40.09%290
07 Aug 2026119−₹20.08%297
06 Aug 2026121+₹90.08%298
05 Aug 2026112+₹80.08%316
04 Aug 2026104+₹60.07%345
03 Aug 202698−₹10.07%353
31 Jul 202699—0.07%358

SHILPAMED within Health Technology

Ranked #14 of 61 funded Health Technology stocks, carrying 2.2% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
12MOREPENLAB
Morepen Laboratories Limited
₹1422.2%
13BLUEJET
Blue Jet Healthcare Limited
₹1412.2%
14SHILPAMED
Shilpa Medicare Limited
₹1402.2%
15GRANULES
Granules India Limited
₹1272.0%
16BIOCON
Biocon Limited
₹1231.9%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.